SBI funds $1 billion for Sun Pharma's US acquisition

9 Jun 2026via ETLegalWorld.comSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

SBI funds $1 billion for Sun Pharma's US acquisition. This funding supports Sun Pharma’s major overseas expansion, marking one of the largest pharma deals by an Indian company. The $1 billion infusion underscores strong banking support for strategic acquisitions. Such a significant move could enhance Sun Pharma’s global footprint and revenue potential.

📊 STOCKS: SUNPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition

#Acquisition#Pharma#Funding

Stocks mentioned

SUNPHARMASUNPHARMA

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →